KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Interest Expenses (2018 - 2025)

Neogenomics (NEO) has disclosed Interest Expenses for 12 consecutive years, with $599000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses fell 63.12% year-over-year to $599000.0, compared with a TTM value of $3.8 million through Dec 2025, down 43.28%, and an annual FY2025 reading of $3.8 million, down 43.28% over the prior year.
  • Interest Expenses was $599000.0 for Q4 2025 at Neogenomics, down from $603000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $5.2 million in Q4 2022 and bottomed at $139000.0 in Q3 2022.
  • Average Interest Expenses over 5 years is $1.7 million, with a median of $1.6 million recorded in 2024.
  • The sharpest move saw Interest Expenses plummeted 89.27% in 2022, then surged 1112.23% in 2023.
  • Year by year, Interest Expenses stood at $4.8 million in 2021, then rose by 7.64% to $5.2 million in 2022, then tumbled by 67.77% to $1.7 million in 2023, then fell by 3.39% to $1.6 million in 2024, then tumbled by 63.12% to $599000.0 in 2025.
  • Business Quant data shows Interest Expenses for NEO at $599000.0 in Q4 2025, $603000.0 in Q3 2025, and $933000.0 in Q2 2025.